Nuclear Medicine/Radiopharmaceuticals Market: The Development Strategies Adopted By Major Key Players
Nuclear Medicine or Radiopharmaceuticals Market Size Was Valued at USD 6.13 Billion in 2022, and is Projected to Reach USD 11.0 Billion by 2030, Growing at a CAGR of 7.6% From 2023-2030.
The nuclear medicine or radiopharmaceuticals market involves the use of radioactive substances for diagnostic and therapeutic purposes in the field of medicine. Radiopharmaceuticals are compounds containing a radionuclide (radioactive isotope) that emit gamma rays. These substances are used in medical imaging, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as in targeted radiotherapy.
You can access a sample report here: https://introspectivemarke...
Nuclear Medicine or Radiopharmaceuticals Market Size Was Valued at USD 6.13 Billion in 2022, and is Projected to Reach USD 11.0 Billion by 2030, Growing at a CAGR of 7.6% From 2023-2030.
The nuclear medicine or radiopharmaceuticals market involves the use of radioactive substances for diagnostic and therapeutic purposes in the field of medicine. Radiopharmaceuticals are compounds containing a radionuclide (radioactive isotope) that emit gamma rays. These substances are used in medical imaging, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as in targeted radiotherapy.
You can access a sample report here: https://introspectivemarke...
10:54 AM - Feb 29, 2024 (UTC)
